CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.

Abstract

Recombinant adeno-associated virus (AAV) is a promising non-pathogenic vector in the emerging field of gene therapy. For AAV serotype 2 (AAV-2) infection, experimental evidence points to an involvement of heparan sulphate proteoglycans (HSPG), but also to the existence of additional receptors. We investigated a potential role of the tetraspanin CD9 in AAV-2… (More)

Topics

5 Figures and Tables

Cite this paper

@article{Kurzeder2007CD9PA, title={CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.}, author={Christian Kurzeder and Bernd Koppold and Georg Sauer and Stefan Pabst and Rolf Kreienberg and Helmut Deissler}, journal={International journal of molecular medicine}, year={2007}, volume={19 2}, pages={325-33} }